Merck cholesterol drug's odds dim after Lilly failure
October 12, 2015 at 20:06 PM EDT
Oct 12 (Reuters) - The odds that Merck & Co's high-stakes cholesterol drug will succeed have dropped dramatically after Eli Lilly and Co said its similar medicine failed to reduce heart attacks and strokes, top U.S. heart doctors said.